Skip to content
TrueView 100 Pro
Navigator System
Navigator System
Navigator Sterilization
MarginProbe
MarginProbe
Breast Cancer
Partial Mastectomy
Lumpectomy Surgery
Ductal Carcinoma in Situ (DCIS)
Lumpectomy Margins
Patients
MarginProbe Advantage
Physicians
Clinical Data
Hemoblast
Clinical Data
Economic Value
Surgical Videos
CoPilot VL
About
Careers
News
Contact
TrueView 100 Pro
Navigator System
Navigator System
Navigator Sterilization
MarginProbe
MarginProbe
Breast Cancer
Partial Mastectomy
Lumpectomy Surgery
Ductal Carcinoma in Situ (DCIS)
Lumpectomy Margins
Patients
MarginProbe Advantage
Physicians
Clinical Data
Hemoblast
Clinical Data
Economic Value
Surgical Videos
CoPilot VL
About
Careers
News
Contact
Contact
Diagnostic Performance of a Novel Device for Real-Time Margin Assessment in Lumpectomy Specimens
January 6, 2010
/
Clinical Data
[vc_row][vc_column][vc_column_text]
View Study
[/vc_column_text][/vc_column][/vc_row]
Posted in
Clinical Data
Posts navigation
← Dilon Devices Appoints William Densel President U.S. and Chief Business Officer
Dilon Completes Enrollment in MarginProbe® Pivotal Trial for Real-Time Detection of Cancer During Breast Conservation Surgery →